標題: Titlebook: Immunotherapy for Gastrointestinal Cancer; David Kerr,Rebecca Johnson Book 2017 Springer International Publishing Switzerland 2017 Cancer. [打印本頁] 作者: Annihilate 時間: 2025-3-21 19:40
書目名稱Immunotherapy for Gastrointestinal Cancer影響因子(影響力)
書目名稱Immunotherapy for Gastrointestinal Cancer影響因子(影響力)學科排名
書目名稱Immunotherapy for Gastrointestinal Cancer網(wǎng)絡公開度
書目名稱Immunotherapy for Gastrointestinal Cancer網(wǎng)絡公開度學科排名
書目名稱Immunotherapy for Gastrointestinal Cancer被引頻次
書目名稱Immunotherapy for Gastrointestinal Cancer被引頻次學科排名
書目名稱Immunotherapy for Gastrointestinal Cancer年度引用
書目名稱Immunotherapy for Gastrointestinal Cancer年度引用學科排名
書目名稱Immunotherapy for Gastrointestinal Cancer讀者反饋
書目名稱Immunotherapy for Gastrointestinal Cancer讀者反饋學科排名
作者: Emg827 時間: 2025-3-21 21:24 作者: 偶像 時間: 2025-3-22 04:09 作者: circumvent 時間: 2025-3-22 07:55
Chris Heery,Anteneh Tesfaye,Benjamin Weinberg,John Marshalle recognized as desirable characteristics for use in reratory viral infections (1). In 1973 Merigan . showed that intranasal administration of human leukocyte interferon (HuIFN-α [Le]) in a total dosage of 14 Mu over 4 days reduced seroconversion and illness rates following experimental rhinovirus t作者: HEW 時間: 2025-3-22 10:21 作者: 慢跑 時間: 2025-3-22 13:50 作者: Glycogen 時間: 2025-3-22 20:32
Eirini Pectasides,David McDermott. It has been investigated in animal models for over a decade, and many publications have provided insight into its advantages and disadvantages. However, in spite of its enormous potential for revealing metabolic processes in normal and pathological tissue, microdialysis in humans is still in its i作者: 地名表 時間: 2025-3-23 00:37 作者: 強有力 時間: 2025-3-23 03:37
Mark A. Glaire,David N. ChurchP is considered to be a macromineral for crop production, but only 15–30 % of applied P fertilizer is taken up by crops. Monogastric animals including humans have much lower efficiency of P utilization because a large quantity of P in feed is in the form of phytate which is unavailable for digestion作者: Phagocytes 時間: 2025-3-23 06:47
Volker Heinemann MD,Sebastian Stintzinglements and minerals, which under certain dietary circumstances leads to calcium, iron and zinc deficiencies. In the last 25 years, however, important healthy beneficial properties of phytate have been observed (antioxidant, anticancer, renal stone prevention, etc.). In this chapter, the effects of 作者: strdulate 時間: 2025-3-23 10:29
bone, and cardiovascular disease in people with chronic kidney disease (CKD). This chapter examines in depth one of these widely used processing tools, the addition of phosphate additives during processing to provide a number of different needed functions that improve processed foods in a variety o作者: 卷發(fā) 時間: 2025-3-23 17:19 作者: Mystic 時間: 2025-3-23 18:57
Cell Based Therapy: Modified Cancer Cells,tions of surgery and adjuvant chemo and/or radiation therapy in treating CRC patients, a greater emphasis has been placed on developing alternative treatment approaches including immunotherapy. This chapter will focus on autologous cell based immunotherapy including adoptive T cell transfer, dendrit作者: 裁決 時間: 2025-3-24 00:24
Therapeutic Cancer Vaccines,in certain cancers, the scientific community has redoubled efforts to expand the impact of these treatments for more patients. Cancer vaccines have been developed and tested in gastrointestinal (GI) cancers for more than two decades, mostly with little success. As a result, there has been little int作者: 無政府主義者 時間: 2025-3-24 05:24 作者: 創(chuàng)新 時間: 2025-3-24 07:58 作者: 無能力 時間: 2025-3-24 12:31
PD1 and PD-L1 Immune Checkpoint Inhibitors in Gastrointestinal Cancer,on and rectum account for 29 % of new cancer cases and 37 % of cancer deaths [1]. The majority of these cancers are diagnosed at an advanced stage and outcomes remain poor. Systemic therapy for gastrointestinal tumours primarily relies on cytotoxic chemotherapy, with very few molecularly targeted ag作者: defenses 時間: 2025-3-24 14:51
The Role of the JAK/STAT Signalling Pathway in Immunoregulation of Gastrointestinal Cancers,ding the way. Better understanding host-tumour interactions will continue to improve our ability to reverse the immune manipulation through which the tumour empowers the immune system to effectively control tumour growth and metastasis. Cytokine signalling mechanisms, such as the Janus kinase (JAK)-作者: Redundant 時間: 2025-3-24 21:59 作者: 不能和解 時間: 2025-3-25 01:18 作者: 他一致 時間: 2025-3-25 06:34
Cell Based Therapy: Modified Cancer Cells,eatment approaches including immunotherapy. This chapter will focus on autologous cell based immunotherapy including adoptive T cell transfer, dendritic cell based vaccines and autologous tumour cell derived vaccines targeting CRC. Also the possibilities of combining immunotherapy with conventional treatment strategies will be briefly explored.作者: GLARE 時間: 2025-3-25 09:00
Antibodies that Inhibit Specific Cellular Pathways in Gastric Cancer,hanisms, such as, complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC). Here, we describe interesting therapeutic targets in gastric cancer and studied antibodies.作者: 貪心 時間: 2025-3-25 13:25
Antibodies for Treatment of Metastatic Colorectal Cancer,de possible not only by the introduction of new chemotherapeutic agents such as irinotecan and oxaliplatin, but also by the availability of targeted agents directed against the epidermal growth factor receptor (EGFR) pathway as well as against the vascular endothelial growth factor (VEGF).作者: 血友病 時間: 2025-3-25 19:35
Book 2017g therapeutic approaches which might be taken under the broad banner of immunotherapy..Starting by introducing concepts of modern immunology, the clinical applications of immunotherapy are then discussed. The reader will learn about the three broad classes of immune therapeutic agents: cell-based tr作者: WAIL 時間: 2025-3-25 23:40 作者: obscurity 時間: 2025-3-26 01:08
Therapeutic Cancer Vaccines, understanding of the past work in cancer vaccines is critical (Fig. 3.1). In this chapter, we will review the most important and representative results of cancer vaccine research in GI cancers. The fundamentals of this work will not only serve future GI cancer research, but also other tumour types.作者: 不能妥協(xié) 時間: 2025-3-26 06:30
https://doi.org/10.1007/978-3-319-43063-8Cancer; Immunotherapy; Vaccine; antibody; cytokine; tumor management作者: Narrative 時間: 2025-3-26 12:16
David Kerr,Rebecca JohnsonExplores recent advances in cancer immunotherapy and their application in clinical practice.Introduces concepts of modern immunology to the oncology expert.Reviews the evidence and scientific lessons 作者: 萬神殿 時間: 2025-3-26 14:30 作者: Foment 時間: 2025-3-26 18:13 作者: 思考 時間: 2025-3-26 21:27 作者: Abutment 時間: 2025-3-27 02:00 作者: 強化 時間: 2025-3-27 09:14 作者: 搜尋 時間: 2025-3-27 10:54
The Role of the JAK/STAT Signalling Pathway in Immunoregulation of Gastrointestinal Cancers,he expression of chemokines that facilitate the influx of immune cells into the tumours. In addition to the immune regulatory function, several components of JAK-STAT signalling, including STAT3 and JAK1, are known to play a direct role in gastrointestinal (GI) cancer oncogenesis, further emphasisin作者: dyspareunia 時間: 2025-3-27 15:16 作者: Fibrin 時間: 2025-3-27 17:50 作者: Notify 時間: 2025-3-27 22:24 作者: 對待 時間: 2025-3-28 02:31
Vanessa Deschoolmeester,David Kerr,Patrick Pauwels,Jan B. Vermorkenief references to these, followed by more detailed expositions of what has come to light in the interim. In keeping with the broadness of the topic the list of references is extremely long, though we are aware that it is still not absolutely comprehensive. It is intended to give readers interested in specific978-3-642-70931-9978-3-642-70929-6作者: 縫紉 時間: 2025-3-28 09:20
Chris Heery,Anteneh Tesfaye,Benjamin Weinberg,John Marshalltime with the nasal mucosa, concentration dependency of antiviral action, and perhaps inactivation of IFN-β by nasal secretions as factors contributing to the relatively high interferon amounts needed to achieve antiviral effects in the nasal mucosa (5–9).作者: 貞潔 時間: 2025-3-28 11:41 作者: ONYM 時間: 2025-3-28 14:39
Do-Youn Oh,Yung-Jue Bangon, and impairment of renal function was scarcely encountered. The results thus indicate that IFN therapy can be appraised as a useful adjunct to treatment of malignant brain tumors. Its application in combination with radiotherapy and chemotherapy may enhance the antitumor efficacy. The data also s作者: 木質(zhì) 時間: 2025-3-28 19:13
